The new position would work “develop data-driven strategies to enhance municipal services and support council priorities.” ...

Ad hoc announcement pursuant to Art. 53 LRComparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth ...

This research was presented at the American College of Gastroenterology’s annual meeting (ACG 2025), alongside new long-term ...

Making complex data volumes clear, accessible, and interpretable at record speed is the key that successful companies in the ...

Microsoft’s earnings this quarter are astronomical. But Microsoft’s earnings conference call was more like astrology.

Data analyses from two real-world trials of Rebyota (fecal microbiota, live-jslm)efficacy and safety will be presented at IDWeek 2025, according to the details of a recent Ferring ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...

PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial is fully enrolledAdditional analysis of data from a Phase 1b clinical trial that included all patients treated with gedatolisib combined ...

Celcuity expects to complete a rolling NDA submission for gedatolisib under the FDA RTOR program by Q4 2025. Click here to ...

Q3 2025 Earnings Call Transcript November 3, 2025 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.05866 EPS, expectations were $0.07. Operator: Good day, and welcome ...

Setting up our organizations to adapt, respond and grow starts with insight: understanding where content lives, how it’s used ...